| IMMX Market Cap History Table | ||||||||||||||||||||||||||||||||
Below is a table of the IMMX market cap history going back to 11/15/2022:
Also see: IMMX Shares Outstanding History and IMMX YTD Return |
IMMX Market Cap History — Immix Biopharma Capitalization Over Time
As of 3/20/2026 Immix Biopharma has a market cap of 482.51 million. Investors often follow the IMMX market cap history to compare the size of the company over time.
This page shows IMMX market capitalization trends over time, with 15 market cap datapoints presented, dating back to 11/15/2022.
| IMMX Market Cap History Chart | |||||||||||||||||||||||||||||||||
IMMX Historical Market Cap: +183.83% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||
| IMMX Stock Price Chart |
| About Immix Biopharma Inc |
| Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the application of chimeric antigen receptor cell therapy (CAR- T) in light chain (AL) Amyloidosis and autoimmune disease. Co.'s lead cell therapy asset is CAR-T NXC-201 for autoimmune disease, relapsed/refractory AL Amyloidosis, and relapsed/refractory multiple myeloma, which is being evaluated in its ongoing Phase Ib/IIa NEXICART-1 (NCT04720313) clinical trial. Its tissue specific therapeutic IMX-110 is in clinical trials as a monotherapy, and in combination with tislelizumab (BeiGene anti-PD-1 - IMMINENT-01 NCT05840835) for advanced solid tumors, such as relapsed/refractory colorectal cancer (CRC). We show 15 historical shares outstanding datapoints in our IMMX shares outstanding history coverage, used to compute IMMX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IMMX market cap history over the course of time is important for investors interested in comparing IMMX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IMMX versus a peer is one thing; comparing IMMX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IMMX can fluctuate over the course of history. With this page we aim to empower investors researching IMMX by allowing them to research the IMMX market cap history. |
| IMMX Current Stock Quote |
Quotes delayed 20 minutes  Free IMMX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| IMMX Share Performance |
| Market Cap Peers |
| Immix Biopharma (IMMX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
IMMY Market Cap History IMNM Market Cap History IMNN Market Cap History IMNP Market Cap History IMPL Market Cap History IMRA Market Cap History IMRX Market Cap History IMUX Market Cap History IMV Market Cap History IMVT Market Cap History More Healthcare companies » |
IMMX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
